Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc for Immunological Recovery in HIV-1 Discordant Patients
NCT01235013Phase 4Unknown
- Sponsor
- Hospital Clínic de Barcelona
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Hospital Clínic de Barcelona. Status: unknown.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01235013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235013.